Literature DB >> 16622700

Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole.

Márcia Eliana da Silva Ferreira1, Iran Malavazi, Marcela Savoldi, Axel A Brakhage, Maria Helena S Goldman, H Stanley Kim, William C Nierman, Gustavo H Goldman.   

Abstract

For a comprehensive evaluation of genes that have their expression modulated during exposure of the mycelia to voriconazole, we performed a large-scale analysis of gene expression in Aspergillus fumigatus using a microarray hybridization approach. By comparing the expression of genes between the reference time and after addition of voriconazole (30, 60, 120, and 240 min), we identified 2,271 genes differentially expressed in the wild-type strain. To validate the expression of some of these genes during exposure to voriconazole, we analyzed 13 genes showing higher expression in the presence of voriconazole by real-time RT-PCR. Although the magnitudes of induction differed between the two experimental systems, in about 85% of the cases they were in good agreement with the microarray data. To our knowledge this is the first study of microarray hybridization analysis for a filamentous fungus exposed to an antifungal agent. In our study, we have observed: (i) a decreased mRNA expression of various ergosterol biosynthesis genes; (ii) increased mRNA levels of genes involved in a variety of cell functions, such as transporters, transcription factors, proteins involved in cell metabolism, and hypothetical proteins; and (iii) the involvement of the cyclic AMP-protein kinase signaling pathway in the increased mRNA expression of several of these genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622700     DOI: 10.1007/s00294-006-0073-2

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  44 in total

Review 1.  The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus.

Authors:  M E da Silva Ferreira; A L Colombo; I Paulsen; Q Ren; J Wortman; J Huang; M H S Goldman; G H Goldman
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

Review 2.  AAA+ proteins: have engine, will work.

Authors:  Phyllis I Hanson; Sidney W Whiteheart
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

Review 3.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA.

Authors:  N Osherov; D P Kontoyiannis; A Romans; G S May
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

5.  Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Authors:  Patrick Marichal; Luc Koymans; Staf Willemsens; Danny Bellens; Peter Verhasselt; Walter Luyten; Marcel Borgers; Frans C S Ramaekers; Frank C Odds; Hugo Vanden Bossche
Journal:  Microbiology       Date:  1999-10       Impact factor: 2.777

6.  Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species.

Authors:  E Mellado; T M Diaz-Guerra; M Cuenca-Estrella; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.

Authors:  E K Manavathu; J A Vazquez; P H Chandrasekar
Journal:  Int J Antimicrob Agents       Date:  1999-08       Impact factor: 5.283

8.  A novel method used to delete a new Aspergillus fumigatus ABC transporter-encoding gene.

Authors:  Kim Langfelder; Stephanie Gattung; Axel A Brakhage
Journal:  Curr Genet       Date:  2002-07-05       Impact factor: 3.886

9.  Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.

Authors:  Katherine S Barker; Sarah Crisp; Nathan Wiederhold; Russell E Lewis; Bart Bareither; James Eckstein; Robert Barbuch; Martin Bard; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2004-06-16       Impact factor: 5.790

10.  Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.

Authors:  Paul A Mann; Raulo M Parmegiani; Shui-Qing Wei; Cara A Mendrick; Xin Li; David Loebenberg; Beth DiDomenico; Roberta S Hare; Scott S Walker; Paul M McNicholas
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more
  59 in total

1.  Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.

Authors:  Yanan Zhao; Padmaja Paderu; Steven Park; Aleksandra Dukhan; Meredith Senter; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Profiling the Aspergillus fumigatus proteome in response to caspofungin.

Authors:  Steven E Cagas; Mohit Raja Jain; Hong Li; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

3.  Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin.

Authors:  Poonam Gautam; Santosh Kumar Upadhyay; Wazid Hassan; Taruna Madan; Ravi Sirdeshmukh; Curam Sreenivasacharlu Sundaram; Wasudev Namdeo Gade; Seemi Farhat Basir; Yogendra Singh; Puranam Usha Sarma
Journal:  Mycopathologia       Date:  2011-07-14       Impact factor: 2.574

4.  Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence.

Authors:  Sanjoy Paul; Daniel Diekema; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2013-10-11

Review 5.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

Review 6.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

7.  Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.

Authors:  Dawoon Chung; Arsa Thammahong; Kelly M Shepardson; Sara J Blosser; Robert A Cramer
Journal:  Mol Microbiol       Date:  2014-05-09       Impact factor: 3.501

8.  Disparate proteome responses of pathogenic and nonpathogenic aspergilli to human serum measured by activity-based protein profiling (ABPP).

Authors:  Susan D Wiedner; Charles Ansong; Bobbie-Jo Webb-Robertson; LeeAnna M Pederson; Suereta Fortuin; Beth A Hofstad; Anil K Shukla; Ellen A Panisko; Richard D Smith; Aaron T Wright
Journal:  Mol Cell Proteomics       Date:  2013-04-18       Impact factor: 5.911

9.  A reliable measure of similarity based on dependency for short time series: an application to gene expression networks.

Authors:  Mônica G Campiteli; Frederico M Soriani; Iran Malavazi; Osame Kinouchi; Carlos A B Pereira; Gustavo H Goldman
Journal:  BMC Bioinformatics       Date:  2009-08-28       Impact factor: 3.169

10.  Identification of possible targets of the Aspergillus fumigatus CRZ1 homologue, CrzA.

Authors:  Frederico M Soriani; Iran Malavazi; Marcela Savoldi; Eduardo Espeso; Taísa M Dinamarco; Luciano A S Bernardes; Márcia E S Ferreira; Maria Helena S Goldman; Gustavo H Goldman
Journal:  BMC Microbiol       Date:  2010-01-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.